Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1171.55x is 292% below its 5-year average of -299.19x, around the middle of its 5-year range (-2409.42x–-5.16x).
6.56% above its 12-month average of -1253.81x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -598.00x.
INTEREST COVERAGE RATIO
-1171.55x
INTEREST COVERAGE RATIO AVG TTM
-1253.81x
INTEREST COVERAGE RATIO AVG 3Y
-626.60x
INTEREST COVERAGE RATIO AVG 5Y
-299.19x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+6.56%
CURRENT VS 3Y AVG
-86.97%
CURRENT VS 5Y AVG
-291.58%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-18277.25%
vs the sector median at left
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$12.24M
Interest Coverage Ratio
-1171.55x
TTM Avg
-1253.81x
3Y Avg
-626.60x
5Y Avg
-299.19x
Market Cap
$12.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.05M
Interest Coverage Ratio
N/A
TTM Avg
4.58x
3Y Avg
5.23x
5Y Avg
12.43x
Market Cap
$12.43M
Interest Coverage Ratio
-128.38x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.46M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.47M
Interest Coverage Ratio
-16.47x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.83M
Interest Coverage Ratio
-20.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.63M
Interest Coverage Ratio
-5.45x
TTM Avg
0.92x
3Y Avg
0.92x
5Y Avg
0.92x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $12.24M | -1171.55x | -1253.81x | -626.60x | -299.19x |
| Lantern Pharma Inc. (LTRN)vs › | $12.25M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.05M | N/A | 4.58x | 5.23x | 12.43x |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.43M | -128.38x | N/A | N/A | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.46M | N/A | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.47M | -16.47x | N/A | N/A | N/A |
| Biofrontera Inc. (BFRI)vs › | $11.83M | -20.24x | N/A | N/A | N/A |
| Cytosorbents Corporation (CTSO)vs › | $12.63M | -5.45x | 0.92x | 0.92x | 0.92x |
| Passage Bio, Inc. (PASG)vs › | $12.77M | N/A | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.29M | N/A | N/A | N/A | N/A |
Interest Coverage
-1171.5x
Debt/Equity
0.01
Current Ratio
10.57
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -598.00x |
| 2026-03-31 | -1644.22x |
| 2025-12-31 | -2409.42x |
| 2025-09-30 | -1017.29x |
| 2025-06-30 | -600.11x |
| 2025-03-31 | -2026.23x |
| 2024-12-31 | -880.86x |
| 2024-09-30 | -365.60x |
| 2024-06-30 | -212.93x |
| 2024-03-31 | -600.59x |
| 2023-12-31 | -604.69x |
| 2023-09-30 | -226.49x |
| 2023-06-30 | -141.77x |
| 2023-03-31 | -19.75x |
| 2022-12-31 | -5.18x |
| 2022-09-30 | -5.16x |
| 2022-06-30 | -7.25x |
| 2022-03-31 | -33.37x |
| 2021-12-31 | -7.18x |
| 2021-09-30 | -13.47x |
| 2021-06-30 | -45.65x |
